Market Research Report

Syndromic Testing Market, Global Outlook and Forecast 2023-2029

  • AMR ID : 7-1116
  • CAT ID : 7
  • Pages : 132
  • Date : May 2023
 

The global Syndromic Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Respiratory Infections Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Syndromic Testing include Thermo Fisher Scientific Inc., Qiagen, Abbott Diagnostics, Vela Diagnostics, Veramarx, Visby Medical, XCR Diagnostics, Beckman Coulter Diagnostics and Becton, Dickinson and Company, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Syndromic testing is the process of using one test to simultaneously target multiple pathogens with overlapping signs and symptoms.Syndromic testing is a type of testing used in medical diagnosis that looks for multiple different infectious agents at the same time, often based on the symptoms and signs exhibited by the patient. This type of testing is usually performed when a patient presents with symptoms that are difficult to diagnose or when there is a suspected outbreak of an infectious disease.Syndromic testing is a useful tool in the diagnosis and management of infectious diseases.
This report aims to provide a comprehensive presentation of the global market for Syndromic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Syndromic Testing. This report contains market size and forecasts of Syndromic Testing in global, including the following market information:
Global Syndromic Testing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Syndromic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Syndromic Testing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Syndromic Testing Market Segment Percentages, by Type, 2022 (%)
Respiratory Infections
Sexually Transmitted Infections (STIs)
Gastrointestinal Infections
Central Nervous System Infections
Others
Global Syndromic Testing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Syndromic Testing Market Segment Percentages, by Application, 2022 (%)
Outbreak Response
Emergency Departments
Travel Medicine
Military Medicine
Public Health Surveillance
Global Syndromic Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Syndromic Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Syndromic Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Syndromic Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific Inc.
Qiagen
Abbott Diagnostics
Vela Diagnostics
Veramarx
Visby Medical
XCR Diagnostics
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc
Bosch Healthcare Solutions GmbH
Genetic Signatures
GenMark Dx (Roche)
Hologic
Roche Molecular Diagnostics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Syndromic Testing, market overview.
Chapter 2: Global Syndromic Testing market size in revenue.
Chapter 3: Detailed analysis of Syndromic Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Syndromic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
1.1 Syndromic Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Syndromic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Syndromic Testing Overall Market Size
2.1 Global Syndromic Testing Market Size: 2022 VS 2029
2.2 Global Syndromic Testing Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Syndromic Testing Players in Global Market
3.2 Top Global Syndromic Testing Companies Ranked by Revenue
3.3 Global Syndromic Testing Revenue by Companies
3.4 Top 3 and Top 5 Syndromic Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Syndromic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Syndromic Testing Players in Global Market
3.6.1 List of Global Tier 1 Syndromic Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Syndromic Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Syndromic Testing Market Size Markets, 2022 & 2029
4.1.2 Respiratory Infections
4.1.3 Sexually Transmitted Infections (STIs)
4.1.4 Gastrointestinal Infections
4.1.5 Central Nervous System Infections
4.1.6 Others
4.2 By Type - Global Syndromic Testing Revenue & Forecasts
4.2.1 By Type - Global Syndromic Testing Revenue, 2018-2023
4.2.2 By Type - Global Syndromic Testing Revenue, 2024-2029
4.2.3 By Type - Global Syndromic Testing Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Syndromic Testing Market Size, 2022 & 2029
5.1.2 Outbreak Response
5.1.3 Emergency Departments
5.1.4 Travel Medicine
5.1.5 Military Medicine
5.1.6 Public Health Surveillance
5.2 By Application - Global Syndromic Testing Revenue & Forecasts
5.2.1 By Application - Global Syndromic Testing Revenue, 2018-2023
5.2.2 By Application - Global Syndromic Testing Revenue, 2024-2029
5.2.3 By Application - Global Syndromic Testing Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Syndromic Testing Market Size, 2022 & 2029
6.2 By Region - Global Syndromic Testing Revenue & Forecasts
6.2.1 By Region - Global Syndromic Testing Revenue, 2018-2023
6.2.2 By Region - Global Syndromic Testing Revenue, 2024-2029
6.2.3 By Region - Global Syndromic Testing Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Syndromic Testing Revenue, 2018-2029
6.3.2 US Syndromic Testing Market Size, 2018-2029
6.3.3 Canada Syndromic Testing Market Size, 2018-2029
6.3.4 Mexico Syndromic Testing Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Syndromic Testing Revenue, 2018-2029
6.4.2 Germany Syndromic Testing Market Size, 2018-2029
6.4.3 France Syndromic Testing Market Size, 2018-2029
6.4.4 U.K. Syndromic Testing Market Size, 2018-2029
6.4.5 Italy Syndromic Testing Market Size, 2018-2029
6.4.6 Russia Syndromic Testing Market Size, 2018-2029
6.4.7 Nordic Countries Syndromic Testing Market Size, 2018-2029
6.4.8 Benelux Syndromic Testing Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Syndromic Testing Revenue, 2018-2029
6.5.2 China Syndromic Testing Market Size, 2018-2029
6.5.3 Japan Syndromic Testing Market Size, 2018-2029
6.5.4 South Korea Syndromic Testing Market Size, 2018-2029
6.5.5 Southeast Asia Syndromic Testing Market Size, 2018-2029
6.5.6 India Syndromic Testing Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Syndromic Testing Revenue, 2018-2029
6.6.2 Brazil Syndromic Testing Market Size, 2018-2029
6.6.3 Argentina Syndromic Testing Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Syndromic Testing Revenue, 2018-2029
6.7.2 Turkey Syndromic Testing Market Size, 2018-2029
6.7.3 Israel Syndromic Testing Market Size, 2018-2029
6.7.4 Saudi Arabia Syndromic Testing Market Size, 2018-2029
6.7.5 UAE Syndromic Testing Market Size, 2018-2029
7 Syndromic Testing Companies Profiles
7.1 Thermo Fisher Scientific Inc.
7.1.1 Thermo Fisher Scientific Inc. Company Summary
7.1.2 Thermo Fisher Scientific Inc. Business Overview
7.1.3 Thermo Fisher Scientific Inc. Syndromic Testing Major Product Offerings
7.1.4 Thermo Fisher Scientific Inc. Syndromic Testing Revenue in Global Market (2018-2023)
7.1.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
7.2 Qiagen
7.2.1 Qiagen Company Summary
7.2.2 Qiagen Business Overview
7.2.3 Qiagen Syndromic Testing Major Product Offerings
7.2.4 Qiagen Syndromic Testing Revenue in Global Market (2018-2023)
7.2.5 Qiagen Key News & Latest Developments
7.3 Abbott Diagnostics
7.3.1 Abbott Diagnostics Company Summary
7.3.2 Abbott Diagnostics Business Overview
7.3.3 Abbott Diagnostics Syndromic Testing Major Product Offerings
7.3.4 Abbott Diagnostics Syndromic Testing Revenue in Global Market (2018-2023)
7.3.5 Abbott Diagnostics Key News & Latest Developments
7.4 Vela Diagnostics
7.4.1 Vela Diagnostics Company Summary
7.4.2 Vela Diagnostics Business Overview
7.4.3 Vela Diagnostics Syndromic Testing Major Product Offerings
7.4.4 Vela Diagnostics Syndromic Testing Revenue in Global Market (2018-2023)
7.4.5 Vela Diagnostics Key News & Latest Developments
7.5 Veramarx
7.5.1 Veramarx Company Summary
7.5.2 Veramarx Business Overview
7.5.3 Veramarx Syndromic Testing Major Product Offerings
7.5.4 Veramarx Syndromic Testing Revenue in Global Market (2018-2023)
7.5.5 Veramarx Key News & Latest Developments
7.6 Visby Medical
7.6.1 Visby Medical Company Summary
7.6.2 Visby Medical Business Overview
7.6.3 Visby Medical Syndromic Testing Major Product Offerings
7.6.4 Visby Medical Syndromic Testing Revenue in Global Market (2018-2023)
7.6.5 Visby Medical Key News & Latest Developments
7.7 XCR Diagnostics
7.7.1 XCR Diagnostics Company Summary
7.7.2 XCR Diagnostics Business Overview
7.7.3 XCR Diagnostics Syndromic Testing Major Product Offerings
7.7.4 XCR Diagnostics Syndromic Testing Revenue in Global Market (2018-2023)
7.7.5 XCR Diagnostics Key News & Latest Developments
7.8 Beckman Coulter Diagnostics
7.8.1 Beckman Coulter Diagnostics Company Summary
7.8.2 Beckman Coulter Diagnostics Business Overview
7.8.3 Beckman Coulter Diagnostics Syndromic Testing Major Product Offerings
7.8.4 Beckman Coulter Diagnostics Syndromic Testing Revenue in Global Market (2018-2023)
7.8.5 Beckman Coulter Diagnostics Key News & Latest Developments
7.9 Becton, Dickinson and Company
7.9.1 Becton, Dickinson and Company Company Summary
7.9.2 Becton, Dickinson and Company Business Overview
7.9.3 Becton, Dickinson and Company Syndromic Testing Major Product Offerings
7.9.4 Becton, Dickinson and Company Syndromic Testing Revenue in Global Market (2018-2023)
7.9.5 Becton, Dickinson and Company Key News & Latest Developments
7.10 Bio-Rad Laboratories, Inc
7.10.1 Bio-Rad Laboratories, Inc Company Summary
7.10.2 Bio-Rad Laboratories, Inc Business Overview
7.10.3 Bio-Rad Laboratories, Inc Syndromic Testing Major Product Offerings
7.10.4 Bio-Rad Laboratories, Inc Syndromic Testing Revenue in Global Market (2018-2023)
7.10.5 Bio-Rad Laboratories, Inc Key News & Latest Developments
7.11 Bosch Healthcare Solutions GmbH
7.11.1 Bosch Healthcare Solutions GmbH Company Summary
7.11.2 Bosch Healthcare Solutions GmbH Business Overview
7.11.3 Bosch Healthcare Solutions GmbH Syndromic Testing Major Product Offerings
7.11.4 Bosch Healthcare Solutions GmbH Syndromic Testing Revenue in Global Market (2018-2023)
7.11.5 Bosch Healthcare Solutions GmbH Key News & Latest Developments
7.12 Genetic Signatures
7.12.1 Genetic Signatures Company Summary
7.12.2 Genetic Signatures Business Overview
7.12.3 Genetic Signatures Syndromic Testing Major Product Offerings
7.12.4 Genetic Signatures Syndromic Testing Revenue in Global Market (2018-2023)
7.12.5 Genetic Signatures Key News & Latest Developments
7.13 GenMark Dx (Roche)
7.13.1 GenMark Dx (Roche) Company Summary
7.13.2 GenMark Dx (Roche) Business Overview
7.13.3 GenMark Dx (Roche) Syndromic Testing Major Product Offerings
7.13.4 GenMark Dx (Roche) Syndromic Testing Revenue in Global Market (2018-2023)
7.13.5 GenMark Dx (Roche) Key News & Latest Developments
7.14 Hologic
7.14.1 Hologic Company Summary
7.14.2 Hologic Business Overview
7.14.3 Hologic Syndromic Testing Major Product Offerings
7.14.4 Hologic Syndromic Testing Revenue in Global Market (2018-2023)
7.14.5 Hologic Key News & Latest Developments
7.15 Roche Molecular Diagnostics
7.15.1 Roche Molecular Diagnostics Company Summary
7.15.2 Roche Molecular Diagnostics Business Overview
7.15.3 Roche Molecular Diagnostics Syndromic Testing Major Product Offerings
7.15.4 Roche Molecular Diagnostics Syndromic Testing Revenue in Global Market (2018-2023)
7.15.5 Roche Molecular Diagnostics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

 
Choose License Type

Single User : $3250


Corporate User : $4225


Why Choose Us ?

24/7 Research support

Quality assurance

Information security

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe